STPG1
O(6)-methylguanine-induced apoptosis 2
Also known as: C1orf201, FLJ33340, MAPO2, STPG1_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q5TH74
- Gene
- STPG1
- Ensembl
- ENSG00000001460
- Chromosome
- 1
- Canonical length
- 334 aa
- Protein class
- Predicted intracellular proteins
- Subcellular location
- Nucleoplasm
OverviewNCBI Gene
Involved in positive regulation of apoptotic process and positive regulation of mitochondrial membrane permeability involved in apoptotic process. Predicted to be located in mitochondrion and nucleus. [provided by Alliance of Genome Resources, Jul 2025]
Canonical amino-acid sequenceUniProt
334 residues, UniProt reviewed canonical sequence.
>Q5TH74|STPG1
1 MDNSAQKNER TGKHPRRASE VQKGFTAAYP TQSSIPFKSQ ASVIPESEKK GFNSQAKRFP
61 HKKNDIPGPG FYNVIHQSPV SNSVSLSKKG TCMFPSMCAR LDTIISKYPA ANAYTIPSDF
121 ISKRDFSNSC SSMFQLPSFM KALKFETPAP NYYNASVSCC KQRNNVCTRA GFMSKTQRGS
181 FAFADKGPPP GHYDINESLV KQSPNTLMSC FKSKTNRGLK LTSTGPGPGY YNPSDCTKVP
241 KKTLFPKNPI LNFSAQPSPL PPKPPFPGPG QYEIVDYLGP RKHFISSASF VSNTSRWTAA
301 PPQPGLPGPA TYKPELPGKQ SFLYNEDKKW IPVLLocalizationUniProt · AlphaFold · HPA
Whether an antibody against STPG1 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.66
- Highest tissue expression
- 26 nTPM
Expression across tissuesHPA
Tissue
- testis: 26 nTPM
- fallopian tube: 16 nTPM
- choroid plexus: 15 nTPM
- retina: 14 nTPM
- cerebellum: 12 nTPM
- cerebral cortex: 11 nTPM
Single-cell type
- late spermatids: 1,128 nCPM
- early spermatids: 295 nCPM
- late primary spermatocytes: 164 nCPM
- ependymal cells: 95 nCPM
- respiratory ciliated cells: 82 nCPM
- choroid plexus epithelial cells: 77 nCPM
Immune cell
- memory B-cell: 2.3 nTPM
- memory CD8 T-cell: 2 nTPM
- naive B-cell: 1.9 nTPM
- plasmacytoid DC: 1.3 nTPM
- T-reg: 1.2 nTPM
- gdT-cell: 0.8 nTPM
Brain region
- choroid plexus: 23 nTPM
- cerebral cortex: 15 nTPM
- thalamus: 14 nTPM
- midbrain: 13 nTPM
- white matter: 13 nTPM
- hypothalamus: 11 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 1.34
- gnomAD pLI
- 0
- gnomAD missense Z
- 0.25
- DepMap mean gene effect
- 0.06
- DepMap dependency class
- none
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 4% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- positive regulation of apoptotic process
- positive regulation of mitochondrial membrane permeability involved in apoptotic process
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads STPG1 as an antibody target. Whether an autoantibody or antibody against STPG1 could matter depends on whether native STPG1 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
STPG1 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label STPG1 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...